The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure

The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy

(2012) Christine Pasero et al.   CURRENT OPINION IN PHARMACOLOGY

Slow Down and Survive: Enigmatic Immunoregulation by BTLA and HVEM

(2010) Theresa L. Murphy et al.   Annual Review of Immunology

BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

(2010) Laurent Derré et al.   JOURNAL OF CLINICAL INVESTIGATION

B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their Function

(2010) N.-E. Serriari et al.   JOURNAL OF IMMUNOLOGY

B and T Lymphocyte Attenuator Tempers Early Infection Immunity

(2009) Y. Sun et al.   JOURNAL OF IMMUNOLOGY

Management of acute liver failure

(2009) R. Todd Stravitz et al.   Nature Reviews Gastroenterology & Hepatology

Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator

(2008) Yoshihiro Oya et al.   ARTHRITIS AND RHEUMATISM

B7-H4-deficient mice display augmented neutrophil-mediated innate immunity

(2008) G. Zhu et al.   BLOOD

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

(2008) M. Hashiguchi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA